Seven West Media shows a notable focus on ASX-listed medtech company Orthocell, a lesser-known player in the sector. Orthocell is based in Perth and specializes in cell regeneration therapies. Founded in 2007 as a spin-off from the University of Western Australia, it currently has a market capitalization fluctuating around $300 million.
Over the past year, Orthocell's value has increased by approximately 80%, reflecting solid growth in this competitive medtech space. Despite this, Orthocell remains one of many smaller medtech companies listed on the ASX.
"Gift 5 articles to anyone you choose each month when you subscribe."
Its rising profile draws attention within the industry, especially from media executives connected to Kerry Stokes, signaling the company's growing significance.
Seven West Media's keen interest in Orthocell suggests strategic media coverage aligned with emerging medtech companies.
Author’s summary: Orthocell, a small but fast-growing ASX-listed medtech firm, is gaining notable media attention due to its innovative therapies and significant stock growth.